Cargando…
P012 Antibiofilm activity of staphylococcal peptide derivative(s) against Candida auris biofilms in vitro and in an animal model of catheter-associated infection
POSTER SESSION 1, SEPTEMBER 21, 2022, 12:30 PM - 1:30 PM: OBJECTIVES: Candida auris has emerged as a major multidrug-resistant nosocomial pathogen worldwide. The organism exhibits a persistent, colonizing phenotype, usually associated with biofilm formation on hospital surfaces, medical equipment,...
Autores principales: | Kumari, Anjna, Sharma, Anayata, Singh, Rachna |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9515859/ http://dx.doi.org/10.1093/mmy/myac072.P012 |
Ejemplares similares
-
P016 Selected trans-Himalayan medicinal plants and their nano-particles express potent antifungal and antibiofilm activity against Candida auris and Candida glabarata
por: Riyaz, Mohammad, et al.
Publicado: (2022) -
Investigating Dual-Species Candida auris and Staphylococcal Biofilm Antiseptic Challenge
por: Gülmez, Dolunay, et al.
Publicado: (2022) -
P090 Biofilm forming capabilities in multi-drug resistant Candida species with special emphasis on Candida auris isolated from intensive care unit patients
por: Yadav, Harshita, et al.
Publicado: (2022) -
P480 A novel zincophore locus in Candida auris?
por: Chakraborty, Tanmoy, et al.
Publicado: (2022) -
P385 Candida auris: a growing threat to global health
por: Varma, Sharin, et al.
Publicado: (2022)